Cargando…
Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin
BACKGROUND: Antimuscarinic agents used in the treatment of overactive bladder (OAB) differ in their potential to impair cognitive function. It is hypothesised that low brain concentrations and relatively low selectivity for the M(1) muscarinic receptor may reduce the potential for adverse central ne...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Blackwell Publishing Ltd
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734922/ https://www.ncbi.nlm.nih.gov/pubmed/18699842 http://dx.doi.org/10.1111/j.1742-1241.2008.01849.x |